Literature DB >> 17204940

Upregulation of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha in leptomeningeal vascular malformations of Sturge-Weber syndrome.

Amina Comati1, Heike Beck, William Halliday, G Jackson Snipes, Karl Heinz Plate, Till Acker.   

Abstract

Cutaneous and leptomeningeal vascular malformations are hallmarks of the Sturge-Weber Syndrome (SWS), resulting in chronic ischemic tissue damage. The mechanisms underlying the pathobiology of these progressive lesions are unknown. Aberrant expression of angiogenic factors has been implicated in the genesis and maintenance of vascular malformations. To assess the role of angiogenesis in SWS vascular lesions we determined the expression of key angiogenic factors by immunohistochemistry and in situ hybridization in 8 SWS patients (age: 8 months to 18 years). We observed increased expression of vascular endothelial growth factor (VEGF), its cognate receptors VEGFR-1, VEGFR-2, and neuropilin (NP)-1 as well as Tie2 in leptomeningeal SWS blood vessels. Intriguingly, these factors are known to be transcriptionally induced by hypoxia-inducible factor (HIF). The HIF system has emerged as the key regulatory system of responses to hypoxia. Immunohistochemical analysis demonstrated markedly elevated nuclear HIF-1alpha and HIF-2alpha protein levels in SWS vessels. Concomitantly, SWS vessels revealed signs of enhanced endothelial cell (EC) turnover as evidenced by increased EC proliferation and apoptosis. Thus, in terms of angiogenesis, vascular malformations in SWS are not static lesions but constitute dynamic structures. Our observation of a dysregulated HIF-alpha expression in SWS vessels are in agreement with recent findings that EC-specific HIF activation provides a setting which supports and sustains angiogenesis and could be of potential use for developing therapeutic strategies to treat these currently incurable lesions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17204940     DOI: 10.1097/nen.0b013e31802d9011

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  16 in total

Review 1.  Current Therapeutic Options in Sturge-Weber Syndrome.

Authors:  Anne Comi
Journal:  Semin Pediatr Neurol       Date:  2015-11-11       Impact factor: 1.636

Review 2.  Presentation, diagnosis, pathophysiology, and treatment of the neurological features of Sturge-Weber syndrome.

Authors:  Anne M Comi
Journal:  Neurologist       Date:  2011-07       Impact factor: 1.398

3.  Increased L-[1-11 C] leucine uptake in the leptomeningeal angioma of sturge-weber syndrome: a PET study.

Authors:  Bálint Alkonyi; Harry T Chugani; Otto Muzik; Diane C Chugani; Senthil K Sundaram; William J Kupsky; Carlos E Batista; Csaba Juhász
Journal:  J Neuroimaging       Date:  2011-01-11       Impact factor: 2.486

4.  Gαq and hyper-phosphorylated ERK expression in Sturge-Weber syndrome leptomeningeal blood vessel endothelial cells.

Authors:  Rebecca J Wellman; Su Bin Cho; Pratibha Singh; Miriya Tune; Carlos A Pardo; Anne M Comi
Journal:  Vasc Med       Date:  2018-08-16       Impact factor: 3.239

5.  Effect of topical propranolol gel on plasma renin, angiotensin II and vascular endothelial growth factor in superficial infantile hemangiomas.

Authors:  Yu-Juan Tang; Zai-Zhong Zhang; Shao-Quan Chen; Shu-Ming Chen; Cheng-Jin Li; Jian-Wei Chen; Bo Yuan; Yin Xia; Lie Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-10-22

6.  Transient focal cortical increase of interictal glucose metabolism in Sturge-Weber syndrome: implications for epileptogenesis.

Authors:  Bálint Alkonyi; Harry T Chugani; Csaba Juhász
Journal:  Epilepsia       Date:  2011-04-11       Impact factor: 5.864

7.  GNAQ Mutation in the Venous Vascular Malformation and Underlying Brain Tissue in Sturge-Weber Syndrome.

Authors:  Senthil K Sundaram; Sharon K Michelhaugh; Neil V Klinger; William J Kupsky; Sandeep Sood; Harry T Chugani; Sandeep Mittal; Csaba Juhász
Journal:  Neuropediatrics       Date:  2017-06-01       Impact factor: 1.947

8.  Brain Vascular Malformation Consortium: Overview, Progress and Future Directions.

Authors:  Amy L Akers; Karen L Ball; Marianne Clancy; Anne M Comi; Marie E Faughnan; Rashmi Gopal-Srivastava; Thomas P Jacobs; Helen Kim; Jeffrey Krischer; Douglas A Marchuk; Charles E McCulloch; Leslie Morrison; Marsha Moses; Claudia S Moy; Ludmilla Pawlikowska; William L Young
Journal:  J Rare Disord       Date:  2013-04-01

Review 9.  Sturge-Weber syndrome: an update on the relevant issues for neurosurgeons.

Authors:  Federico Bianchi; Anna Maria Auricchio; Domenica Immacolata Battaglia; Daniela Rosaria Pia Chieffo; Luca Massimi
Journal:  Childs Nerv Syst       Date:  2020-06-21       Impact factor: 1.475

10.  Prolyl hydroxylase 3 involvement in lung cancer progression under hypoxic conditions: association with hypoxia-inducible factor-1α and pyruvate kinase M2.

Authors:  Xiao Chu; Ming Xiang; Liang Feng; Hui Liu; Chao Zhou
Journal:  J Thorac Dis       Date:  2019-09       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.